GlassScriptPhysician profile
Conrad C Nievera
NPI 1346292018
$24,299.28
in general payments reported to CMS, 2019-2025
46 companies · $3,535 in 2025
The $3,535 reported for 2025 was more than what 81% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,690 · 2020: $4,501 · 2021: $2,945 · 2022: $1,627 · 2023: $782 · 2024: $3,219 · 2025: $3,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,672 · Travel and Lodging: $3,239 · Consulting Fee: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,672.35 |
| Travel and Lodging | $3,238.68 |
| Consulting Fee | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $9,651.52 | 2019-2021 | |
| Livanova USA, INC. | $4,707.29 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Jazz Pharmaceuticals INC. | $868.38 | 2022-2025 | |
| Genzyme Corporation | $847.45 | 2019-2020 | |
| Greenwich Biosciences, INC. | $719.99 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $652.89 | 2021-2024 | Ultomiris |
| Medtronic USA, INC. | $636.62 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $625.00 | 2025 | |
| Biogen, INC. | $590.02 | 2019-2025 | Tysabri, Vumerity |
| Harmony Biosciences LLC | $389.26 | 2021-2024 | Wakix |
| Sk Life Science, INC. | $374.72 | 2020-2023 | Xcopri |
| Eisai INC. | $325.75 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $325.67 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $243.97 | 2019-2022 | |
| Argenx US, INC. | $235.50 | 2022-2025 | Vyvgart |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Nievera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.